Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Maravai LifeSciences Holdings, Inc. (MRVI) had Debt to Capital Ratio of 0.41 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$47.40M |
|
$-39.59M |
|
$39.63M |
|
$7.77M |
|
$113.67M |
|
$-66.28M |
|
$-7.85M |
|
$-74.12M |
|
$-74.12M |
|
$-69.84M |
|
$-69.84M |
|
$-69.84M |
|
$-69.84M |
|
$-66.28M |
|
$-20.05M |
|
144.24M |
|
144.24M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$359.76M |
|
$162.73M |
|
$537.21M |
|
$896.97M |
|
$69.68M |
|
$319.09M |
|
$359.30M |
|
$428.98M |
|
$467.98M |
|
$145.49M |
|
$467.98M |
|
255.30M |
|
| Cash Flow Statement Financials | |
$-19.66M |
|
$-26.36M |
|
$-6.43M |
|
$322.40M |
|
$269.91M |
|
$-52.49M |
|
$17.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.16 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.41 |
0.70 |
|
16.39% |
|
-139.84% |
|
-139.84% |
|
-- |
|
-156.39% |
|
-83.53% |
|
$-27.76M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.85 |
|
1.70 |
|
52.94 |
|
-14.92% |
|
-48.00% |
|
-7.79% |
|
-8.87% |
|
$1.83 |
|
$-0.19 |
|
$-0.14 |
|